Monitoring tat peptide binding to TAR RNA by solid-state 31P-19F REDOR NMR.

PubWeight™: 0.94‹?›

🔗 View Article (PMC 1151589)

Published in Nucleic Acids Res on June 16, 2005

Authors

Greg L Olsen1, Thomas E Edwards, Pritilekha Deka, Gabriele Varani, Snorri Th Sigurdsson, Gary P Drobny

Author Affiliations

1: Department of Chemistry, University of Washington Seattle, WA 98195-1700, USA.

Articles cited by this

Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell (1987) 11.15

Conformation of the TAR RNA-arginine complex by NMR spectroscopy. Science (1992) 5.08

Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci U S A (1989) 5.03

A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. Genes Dev (1990) 4.96

Fragments of the HIV-1 Tat protein specifically bind TAR RNA. Science (1990) 4.33

Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition. Genes Dev (1991) 4.15

SIMPSON: a general simulation program for solid-state NMR spectroscopy. J Magn Reson (2000) 4.04

HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J (1990) 3.92

Arginine-mediated RNA recognition: the arginine fork. Science (1991) 3.89

RNA recognition by Tat-derived peptides: interaction in the major groove? Cell (1991) 3.83

Tackling Tat. J Mol Biol (1999) 3.13

The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. J Mol Biol (1995) 2.93

Current topics in RNA-protein recognition: control of specificity and biological function through induced fit and conformational capture. Biochemistry (2001) 2.80

Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge. Nucleic Acids Res (1996) 2.55

High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. J Mol Biol (1993) 2.44

Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro. Proc Natl Acad Sci U S A (1990) 2.32

Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence. J Virol (1990) 2.20

Role of RNA structure in arginine recognition of TAR RNA. Proc Natl Acad Sci U S A (1993) 1.94

Specific binding of arginine to TAR RNA. Proc Natl Acad Sci U S A (1992) 1.90

Concerted motions in HIV-1 TAR RNA may allow access to bound state conformations: RNA dynamics from NMR residual dipolar couplings. J Mol Biol (2002) 1.86

Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA. Arch Biochem Biophys (1999) 1.66

RNA binding assays for Tat-derived peptides: implications for specificity. Biochemistry (1992) 1.65

Activity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1989) 1.57

Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein. J Virol (1991) 1.45

Solution structure of the HIV-2 TAR-argininamide complex. J Mol Biol (1997) 1.44

The bend in RNA created by the trans-activation response element bulge of human immunodeficiency virus is straightened by arginine and by Tat-derived peptide. Proc Natl Acad Sci U S A (1995) 1.38

Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots". J Mol Biol (2004) 1.37

Structure and dynamics of a DNA.RNA hybrid duplex with a chiral phosphorothioate moiety: NMR and molecular dynamics with conventional and time-averaged restraints. Biochemistry (1995) 1.35

Characterization of the solution conformations of unbound and Tat peptide-bound forms of HIV-1 TAR RNA. Biochemistry (1999) 1.34

Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA. J Mol Biol (2004) 1.29

Phosphorothioate substitution can substantially alter RNA conformation. Biochemistry (2000) 1.25

Kinking of RNA helices by bulged bases, and the structure of the human immunodeficiency virus transactivator response element. J Mol Biol (1992) 1.24

Argininamide binding arrests global motions in HIV-1 TAR RNA: comparison with Mg2+-induced conformational stabilization. J Mol Biol (2004) 1.21

Circular dichroism studies suggest that TAR RNA changes conformation upon specific binding of arginine or guanidine. Biochemistry (1992) 1.21

Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B. J Biol Chem (2000) 1.20

Base flexibility in HIV-2 TAR RNA mapped by solution (15)N, (13)C NMR relaxation. J Mol Biol (2002) 1.20

Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator. Proc Natl Acad Sci U S A (1992) 1.11

Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening. Chem Biol (2002) 1.06

Towards structural genomics of RNA: rapid NMR resonance assignment and simultaneous RNA tertiary structure determination using residual dipolar couplings. J Mol Biol (2002) 1.03

Dissection of the proposed base triple in human immunodeficiency virus TAR RNA indicates the importance of the Hoogsteen interaction. Biochemistry (1997) 0.99

Structure of a stereoregular phosphorothioate DNA/RNA duplex. Nat Struct Biol (1998) 0.97

Investigation of RNA-protein and RNA-metal ion interactions by electron paramagnetic resonance spectroscopy. The HIV TAR-Tat motif. Chem Biol (2002) 0.94

Determination of DNA minor groove width in distamycin-DNA complexes by solid-state NMR. Nucleic Acids Res (2003) 0.93

Recognition of an unnatural difluorophenyl nucleotide by uracil DNA glycosylase. Biochemistry (2004) 0.88

Identification of amino acids that promote specific and rigid TAR RNA-tat protein complex formation. Chem Biol (2005) 0.84

Structure of a quinobenzoxazine--G-quadruplex complex by REDOR NMR. Biochemistry (2004) 0.84

Isotope labeling for 13C relaxation measurements on RNA. Methods Enzymol (1995) 0.82

Articles by these authors

Design of a novel globular protein fold with atomic-level accuracy. Science (2003) 13.06

RNA-binding proteins: modular design for efficient function. Nat Rev Mol Cell Biol (2007) 5.33

Transition state stabilization by a catalytic RNA. Science (2002) 2.73

The structure and function of small nucleolar ribonucleoproteins. Nucleic Acids Res (2007) 2.50

Strong correlation between SHAPE chemistry and the generalized NMR order parameter (S2) in RNA. J Am Chem Soc (2008) 2.26

Recognition of GU-rich polyadenylation regulatory elements by human CstF-64 protein. EMBO J (2003) 2.01

Cocrystal structure of a class I preQ1 riboswitch reveals a pseudoknot recognizing an essential hypermodified nucleobase. Nat Struct Mol Biol (2009) 1.88

Protein families and RNA recognition. FEBS J (2005) 1.65

The Cbf5-Nop10 complex is a molecular bracket that organizes box H/ACA RNPs. Nat Struct Mol Biol (2005) 1.52

High-resolution structural and thermodynamic analysis of extreme stabilization of human procarboxypeptidase by computational protein design. J Mol Biol (2006) 1.49

Structure of stem-loop IV of Tetrahymena telomerase RNA. EMBO J (2006) 1.49

Thermodynamic analysis of ligand binding and ligand binding-induced tertiary structure formation by the thiamine pyrophosphate riboswitch. RNA (2009) 1.48

The highly cooperative folding of small naturally occurring proteins is likely the result of natural selection. Cell (2007) 1.46

Structure of hepatitis C virus polymerase in complex with primer-template RNA. J Virol (2012) 1.39

High-throughput protein production and purification at the Seattle Structural Genomics Center for Infectious Disease. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 1.37

Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots". J Mol Biol (2004) 1.37

Structural basis for specific, high-affinity tetracycline binding by an in vitro evolved aptamer and artificial riboswitch. Chem Biol (2008) 1.35

Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein. Proc Natl Acad Sci U S A (2009) 1.33

Isolation and characterization of a thermostable RNA ligase 1 from a Thermus scotoductus bacteriophage TS2126 with good single-stranded DNA ligation properties. Nucleic Acids Res (2005) 1.32

Cooperative interaction of transcription termination factors with the RNA polymerase II C-terminal domain. Nat Struct Mol Biol (2010) 1.32

A conserved RNA structure within the HCV IRES eIF3-binding site. Nat Struct Biol (2002) 1.31

Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets. Proc Natl Acad Sci U S A (2012) 1.28

An all-atom, distance-dependent scoring function for the prediction of protein-DNA interactions from structure. Proteins (2007) 1.28

Structural genomics of infectious disease drug targets: the SSGCID. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 1.27

Sum frequency generation and solid-state NMR study of the structure, orientation, and dynamics of polystyrene-adsorbed peptides. Proc Natl Acad Sci U S A (2010) 1.27

A new hydrogen-bonding potential for the design of protein-RNA interactions predicts specific contacts and discriminates decoys. Nucleic Acids Res (2004) 1.27

A knowledge-based potential function predicts the specificity and relative binding energy of RNA-binding proteins. FEBS J (2007) 1.26

NMR studies of dynamics in RNA and DNA by 13C relaxation. Biopolymers (2007) 1.24

SAD phasing using iodide ions in a high-throughput structural genomics environment. J Struct Funct Genomics (2011) 1.23

Combining functional and structural genomics to sample the essential Burkholderia structome. PLoS One (2013) 1.21

Nanometer distance measurements on RNA using PELDOR. J Am Chem Soc (2003) 1.21

Structure-guided peptidomimetic design leads to nanomolar beta-hairpin inhibitors of the Tat-TAR interaction of bovine immunodeficiency virus. Biochemistry (2007) 1.20

How binding of small molecule and peptide ligands to HIV-1 TAR alters the RNA motional landscape. Nucleic Acids Res (2009) 1.20

The C-terminal domains of vertebrate CstF-64 and its yeast orthologue Rna15 form a new structure critical for mRNA 3'-end processing. J Biol Chem (2006) 1.20

Real-time multidimensional NMR follows RNA folding with second resolution. Proc Natl Acad Sci U S A (2010) 1.18

Folding of the C-terminal bacterial binding domain in statherin upon adsorption onto hydroxyapatite crystals. Proc Natl Acad Sci U S A (2006) 1.18

13C NMR relaxation studies of RNA base and ribose nuclei reveal a complex pattern of motions in the RNA binding site for human U1A protein. J Mol Biol (2005) 1.18

Hydration dependent dynamics in RNA. J Biomol NMR (2009) 1.17

Relative orientation of rigid nitroxides by PELDOR: beyond distance measurements in nucleic acids. Angew Chem Int Ed Engl (2009) 1.15

A new alpha-helical extension promotes RNA binding by the dsRBD of Rnt1p RNAse III. EMBO J (2004) 1.12

Assembly of alpha-helical peptide coatings on hydrophobic surfaces. J Am Chem Soc (2002) 1.12

Structural mimicry of retroviral tat proteins by constrained beta-hairpin peptidomimetics: ligands with high affinity and selectivity for viral TAR RNA regulatory elements. J Am Chem Soc (2004) 1.11

A solid-state deuterium NMR and sum-frequency generation study of the side-chain dynamics of peptides adsorbed onto surfaces. J Am Chem Soc (2009) 1.10

A REDOR NMR study of a phosphorylated statherin fragment bound to hydroxyapatite crystals. J Am Chem Soc (2005) 1.09

TAR RNA recognition by a cyclic peptidomimetic of Tat protein. Biochemistry (2005) 1.09

Molecular recognition at the protein-hydroxyapatite interface. Crit Rev Oral Biol Med (2003) 1.08

A nucleoside that contains a rigid nitroxide spin label: a fluorophore in disguise. Angew Chem Int Ed Engl (2007) 1.08

Structure and stability of wild-type and mutant RNA internal loops from the SL-1 domain of the HIV-1 packaging signal. J Mol Biol (2002) 1.07

Protein and RNA dynamics play key roles in determining the specific recognition of GU-rich polyadenylation regulatory elements by human Cstf-64 protein. J Mol Biol (2005) 1.07

How arginine-rich domains coordinate mRNA maturation events. RNA Biol (2007) 1.07

The solution structure of an essential stem-loop of human telomerase RNA. Nucleic Acids Res (2003) 1.06

Structural basis for stabilization of the tau pre-mRNA splicing regulatory element by novantrone (mitoxantrone). Chem Biol (2009) 1.06

The structure of an enzyme-activating fragment of human telomerase RNA. RNA (2005) 1.06

Engineering RNA-binding proteins for biology. FEBS J (2013) 1.06

γ-AApeptides bind to RNA by mimicking RNA-binding proteins. Org Biomol Chem (2011) 1.06

Validation of automated docking programs for docking and database screening against RNA drug targets. J Med Chem (2004) 1.05

Binding of U1A protein changes RNA dynamics as observed by 13C NMR relaxation studies. Biochemistry (2007) 1.05

Solid-state deuterium NMR studies reveal micros-ns motions in the HIV-1 transactivation response RNA recognition site. J Am Chem Soc (2008) 1.05

Studying RNA using site-directed spin-labeling and continuous-wave electron paramagnetic resonance spectroscopy. Methods Enzymol (2009) 1.03

Amide or amine: determining the origin of the 3300 cm(-1) NH mode in protein SFG spectra using 15N isotope labels. J Phys Chem B (2009) 1.01

Folding of the cocaine aptamer studied by EPR and fluorescence spectroscopies using the bifunctional spectroscopic probe Ç. Nucleic Acids Res (2009) 1.01

Essential structural requirements for specific recognition of HIV TAR RNA by peptide mimetics of Tat protein. Nucleic Acids Res (2010) 1.00

Novel protein-protein contacts facilitate mRNA 3'-processing signal recognition by Rna15 and Hrp1. J Mol Biol (2010) 1.00

The box H/ACA RNP assembly factor Naf1p contains a domain homologous to Gar1p mediating its interaction with Cbf5p. J Mol Biol (2007) 0.99

The Protein Maker: an automated system for high-throughput parallel purification. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.99

Trityl radicals: spin labels for nanometer-distance measurements. Chemistry (2012) 0.98

Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA. PLoS Pathog (2011) 0.97

Rigid spin-labeled nucleoside C: a nonperturbing EPR probe of nucleic acid conformation. Nucleic Acids Res (2008) 0.97

Structural investigation of a high-affinity MnII binding site in the hammerhead ribozyme by EPR spectroscopy and DFT calculations. Effects of neomycin B on metal-ion binding. Chembiochem (2003) 0.97

Homonuclear and heteronuclear NMR studies of a statherin fragment bound to hydroxyapatite crystals. J Phys Chem B (2006) 0.96

Electron paramagnetic resonance dynamic signatures of TAR RNA-small molecule complexes provide insight into RNA structure and recognition. Biochemistry (2002) 0.96

Crystal structure of interleukin-6 in complex with a modified nucleic acid ligand. J Biol Chem (2014) 0.96

High-resolution structural validation of the computational redesign of human U1A protein. Structure (2006) 0.96

A (13)C{(31)P} REDOR NMR investigation of the role of glutamic acid residues in statherin- hydroxyapatite recognition. Langmuir (2009) 0.95

Design of beta-hairpin peptidomimetics that inhibit binding of alpha-helical HIV-1 Rev protein to the rev response element RNA. Angew Chem Int Ed Engl (2007) 0.95

Mitoxantrone analogues as ligands for a stem-loop structure of tau pre-mRNA. J Med Chem (2009) 0.94

Investigation of RNA-protein and RNA-metal ion interactions by electron paramagnetic resonance spectroscopy. The HIV TAR-Tat motif. Chem Biol (2002) 0.94

Site-specific incorporation of nitroxide spin-labels into 2'-positions of nucleic acids. Nat Protoc (2007) 0.94

Cell-free production of functional Plasmodium falciparum dihydrofolate reductase-thymidylate synthase. Mol Biochem Parasitol (2006) 0.93

Determination of DNA minor groove width in distamycin-DNA complexes by solid-state NMR. Nucleic Acids Res (2003) 0.93

Mis-translation of a computationally designed protein yields an exceptionally stable homodimer: implications for protein engineering and evolution. J Mol Biol (2006) 0.93

Structure of the yeast SR protein Npl3 and Interaction with mRNA 3'-end processing signals. J Mol Biol (2007) 0.93

EPR spectroscopic analysis of U7 hammerhead ribozyme dynamics during metal ion induced folding. Biochemistry (2005) 0.92

Leveraging structure determination with fragment screening for infectious disease drug targets: MECP synthase from Burkholderia pseudomallei. J Struct Funct Genomics (2011) 0.92

Thermodynamic roles of basic amino acids in statherin recognition of hydroxyapatite. Biochemistry (2007) 0.92

A solid-state NMR study of the dynamics and interactions of phenylalanine rings in a statherin fragment bound to hydroxyapatite crystals. J Am Chem Soc (2006) 0.91

13C relaxation studies of the DNA target sequence for hhai methyltransferase reveal unique motional properties. Biochemistry (2008) 0.91

The structure of a Burkholderia pseudomallei immunophilin-inhibitor complex reveals new approaches to antimicrobial development. Biochem J (2011) 0.91

Theory of nonrigid rotational motion applied to NMR relaxation in RNA. J Phys Chem A (2011) 0.91

Solid State NMR Studies of Molecular Recognition at Protein-Mineral Interfaces. Prog Nucl Magn Reson Spectrosc (2007) 0.90

The Role of Basic Amino Acids in the Molecular Recognition of Hydroxyapatite by Statherin using Solid State NMR. Surf Sci (2010) 0.90

Orientation selection in distance measurements between nitroxide spin labels at 94 GHz EPR with variable dual frequency irradiation. Phys Chem Chem Phys (2013) 0.90

Intermediate rate atomic trajectories of RNA by solid-state NMR spectroscopy. J Am Chem Soc (2010) 0.89

A model for C74 addition by CCA-adding enzymes: C74 addition, like C75 and A76 addition, does not involve tRNA translocation. J Biol Chem (2006) 0.89